← Back to headlines
Pfizer and Astellas Pharma Announce Positive Results for PADCEVTM Clinical Trial
Pfizer Inc. and Astellas Pharma have announced positive results from their Phase 3 EV-304 clinical trial for the drug PADCEVTM.
1 Mar, 09:27 — 1 Mar, 09:27
Sources
Showing 1 of 1 sources
Related Stories
Cyclospora Outbreak Linked to Iceberg Lettuce Expands to Three Additional States
2h ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
4h ago
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
8h ago
West Nile Virus Outbreaks Spread Across Greece and North Macedonia
9h ago